Assessment of radionuclidic impurities in cyclotron produced (99m)Tc. 2012

Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
Nuclear Physics Institute, Academy of Sciences of the Czech Republic, vvi, Husinec-Řež, Czech Republic. lebeda@ujf.cas.cz

BACKGROUND The commercial viability of cyclotron-produced (99m)Tc as an alternative to generator-produced (99m)Tc depends on several factors. These include: production yield, ease of target processing and recycling of (100)Mo, radiochemical purity, specific activity as well as the presence of other radionuclides, particularly various Tc radioisotopes that cannot be separated chemically and will remain in the final clinical preparation. These Tc radionuclidic impurities are derived from nuclear interactions of the accelerated protons with other stable Mo isotopes present in the enriched (100)Mo target. The aim of our study was to determine experimentally the yields of Tc radioisotopes produced from these stable Mo isotopes as a function of incident beam energy in order to predict radionuclidic purity of (99m)Tc produced in highly enriched (100)Mo targets of known isotopic composition. METHODS Enriched molybdenum targets of (95)Mo, (96)Mo, (97)Mo, (98)Mo and (100)Mo were prepared by pressing powdered metal into an aluminum target support. The thick targets were bombarded with 10 to 24MeV protons using the external beam line of the U-120M cyclotron of the Nuclear Physics Institute, Řež. The thick target yields of (94)Tc, (94m)Tc, (95)Tc, (95m)Tc, (96m+g)Tc and (97m)Tc were derived from their activities measured by γ spectrometry using a high purity Ge detector. These data were then used to assess the effect of isotopic composition of highly enriched (100)Mo targets on the radionuclidic purity of (99m)Tc as a function of proton beam energy. Estimates were validated by comparison to measured activities of Tc radioisotopes in proton irradiated, highly enriched (100)Mo targets of known isotopic composition. RESULTS The measured thick target yields of (94)Tc, (94m)Tc, (95)Tc, (95m)Tc, (96m+g)Tc and (97m)Tc correspond well with recently published values calculated via the EMPIRE-3 code. However, the measured yields are more favourable with regard to achievable radionuclidic purity of (99m)Tc. Reliability of the measured thick target yields was demonstrated by comparison of the estimated and measured activities of (94)Tc, (95)Tc, (95m)Tc, and (96m+g)Tc in highly enriched (100)Mo (99%) targets that showed good agreement, with maximum differences within estimated uncertainties. Radioisotopes (94m)Tc and (97m)Tc were not detected in the irradiated (100)Mo targets due to their low activities and measurement conditions; on the other hand we detected small amounts of the short-lived positron emitter (93)Tc (T(½)=2.75h). In addition to (99m)Tc and trace amounts of the various Tc isotopes, significant activities of (96)Nb, (97)Nb and (99)Mo were detected in the irradiated (100)Mo targets. CONCLUSIONS Radioisotope formation during the proton irradiation of Mo targets prepared from different, enriched stable Mo isotopes provides a useful data base to predict the presence of Tc radionuclidic impurities in (99m)Tc derived from proton irradiated (100)Mo targets of known isotopic composition. The longer-lived Tc isotopes including (94)Tc (T(½)=4.883h), (95)Tc (T(½)=20.0h), (95m)Tc (T(½)=61 d), (96m+g)Tc (T(½)=4.24 d) and (97m)Tc (T(½)=90 d) are of particular concern since they may affect the dosimetry in clinical applications. Our data demonstrate that cyclotron production of (99m)Tc, using highly enriched (100)Mo targets and 19-24MeV incident proton energy, will result in a product of acceptable radionuclidic purity for applications in nuclear medicine.

UI MeSH Term Description Entries
D008982 Molybdenum A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. Molybdenum-98,Molybdenum 98
D011854 Radiochemistry The study of the chemical and physical phenomena of radioactive substances. Radiochemistries
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015609 Organotechnetium Compounds Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents. Compounds, Organotechnetium
D017357 Cyclotrons Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field. Synchrocyclotrons,Cyclotron,Synchrocyclotron

Related Publications

Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
November 2015, Physics in medicine and biology,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
March 2019, Medical physics,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
April 2018, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
May 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
September 2018, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
June 2016, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
May 2015, Physics in medicine and biology,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
October 2013, Nuclear medicine and biology,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
March 1985, Radioisotopes,
Ondřej Lebeda, and Erik J van Lier, and Jan Štursa, and Jan Ráliš, and Alexander Zyuzin
November 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!